Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.860
-0.050 (-2.62%)
Apr 28, 2026, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 208.08 million as of April 28, 2026. Its market cap has increased by 103.14% in one year.
Market Cap
208.08M
Enterprise Value
186.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.86
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 208.08M, an increase of 120.62%. That is a compound annual growth rate of 11.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 213.68M | 63.91% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 281.70M |
| Organigram Global | 277.05M |
| Aurora Cannabis | 272.57M |
| Auxly Cannabis Group | 207.70M |
| Cannara Biotech | 179.78M |
| BioSyent | 168.72M |
| Charlotte's Web Holdings | 155.75M |
| Ascend Wellness Holdings | 144.29M |